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Volume 59, Number 6 Abstracts 1749insufﬁciency in patients with multiple sclerosis. This has called into question
the existence of the disorder and the role of venous stenoses in the etiology
of multiple sclerosis. The primary aim of the current study was to clarify
whether venous blockages were unique to multiple sclerosis. A secondary
aim was to assess sensitivity and speciﬁcity of the Zamboni Doppler ultra-
sound spinal venous insufﬁciency criteria compared with catheter venography.
In the current paper, the authors did not assess the effect of venous endovas-
cular procedures in multiple sclerosis. This was an assessor-blinded, case-con-
trol, multicenter study of people with multiple sclerosis, unaffected siblings,
and unrelated healthy volunteers. Study participants were enrolled between
January 2011 and March 2012 and consisted of 177 adults (79 with multiple
sclerosis, 55 siblings, and 43 unrelated controls). Patients were recruited from
three centers in Canada. Narrowing of the internal jugular and azygous veins
was assessed with catheter venography and ultrasound criteria for chronic ce-
rebrospinal venous insufﬁciency proposed by Zamboni et al. Catheter venog-
raphy data were available from 149 participants and ultrasound data from
171. Catheter venography criteria for chronic cerebrospinal venous insufﬁ-
ciency were positive for 1 of 65 (2%) people with multiple sclerosis, 1 of
46 siblings (2%), and 1 of 32 unrelated controls (3%; P ¼ 1.0 for all compar-
isons). Greater than 50% narrowing of any major vein was present in 48 of 65
people (74%) with multiple sclerosis, 31 of 47 siblings (66%; P ¼ .41 for com-
parison with patients with multiple sclerosis), and 26 of 37 unrelated controls
(70%; P ¼ .82). Ultrasound criteria for chronic cerebrospinal venous insufﬁ-
ciency were fulﬁlled in 35 of 79 patients (44%) with multiple sclerosis, 17 of
54 siblings (31%; P ¼ .15 for comparison with patients with multiple scle-
rosis), and 17 of 38 unrelated controls (45%; P ¼ .98). The sensitivity of
the ultrasound criteria for detection of >50% narrowing on catheter venog-
raphy was 0.406 (95% conﬁdence interval, 0.311-0.508), and speciﬁcity
was 0.643 (95% conﬁdence interval, 0.480-0.780).
Comment: The data indicate that chronic cerebrospinal venous insuf-
ﬁciency is rare in both patients with multiple sclerosis and in healthy pa-
tients. On the other hand, extracranial venous narrowing of >50% is a
frequent ﬁnding in patients with multiple sclerosis, unaffected siblings,
and unrelated controls. In addition, the ultrasound criteria proposed by
Zamboni et al for venous stenosis appear neither sensitive nor speciﬁc for
narrowing detected with catheter venography. As such, the study can be
considered another important step in disproving the signiﬁcance of venous
narrowing in the etiology of multiple sclerosis.
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Conclusions: There are comparable outcomes using combined coro-
nary artery bypass grafting and simultaneous carotid endarterectomy as wellas with the use of a staged approach for synchronous carotid and coronary
artery disease.
Summary: There is a strong association between carotid artery ste-
nosis and coronary artery disease. About 28% of patients who are candi-
dates for carotid endarterectomy have signiﬁcant coronary artery
disease, and 12% of patients undergoing myocardial revascularization
will have signiﬁcant carotid artery stenosis (Schwartz LB et al, J Vasc
Surg 1995;21:146-53; and Steinvil A et al, J Am Coll Cardiol
2011;57:779-83). A number of institutional case series have explored sur-
gical options in the management of simultaneous coronary and carotid ar-
tery disease. There have been no randomized controlled trials, and
therefore, guidelines for the management of these patients are based on
institutional single-center retrospective studies. In this study, the authors
performed a systematic literature review and meta-analysis to compare
staged intervention with synchronous management in patients with
concomitant carotid and coronary artery disease. The primary end points
were early mortality and stroke. The search terms “carotid artery disease,”
“carotid endarterectomy,” and “coronary artery bypass grafting” were
used alone or in combination to search English language publications.
End points were mortality, major stroke, and major postoperative
morbidity, myocardial infarction and stroke, and combined early mortality
or stroke. Early events were compared using pooled estimates of risk ratios
(RRs; random effects model) using the inverse-variance method. They
identiﬁed 12 studies with a total of 17,469 and 7552 patients in the com-
bined and staged groups, respectively. Analysis revealed no difference in
early mortality (RR, 1.36; 95% conﬁdence interval [CI], 0.78-2.36; P ¼
.27), postoperative stroke (RR, 1.14; 95% CI, 0.99-1.31; P ¼ .07), com-
bined early mortality or stroke (RR, 1.08; 95% CI, 0.98-1.201; P ¼ .11),
and the combined end point of myocardial infarction or stroke (RR, 0.75;
95% CI, 0.48-1.17; I2 ¼ 11%; P ¼ .2) between the two surgical
approaches.
Comment: The authors’ analysis suggests that the two strategies of
simultaneous vs staged carotid endarterectomy and coronary artery bypass
grafting for patients with combined carotid and coronary disease can both
be used in clinical practice and perhaps are interchangeable approaches.
There may be speciﬁc applications linked to speciﬁc clinical conditions. It
may be that patient speciﬁcs are more important determiners of postopera-
tive morbidity and mortality than performance of synchronous or staged
procedures. The paper clearly does not answer the question about what
approach to use in an individual patient but suggests that clinicians may
choose whatever approach seems best to them, that there may be speciﬁc
conditions where one is better than another, and that these conditions
may be both institution-speciﬁc and patient-speciﬁc. This is still an area
where a randomized trial seems reasonable to provide additional guidance
for the treatment of these complex patients.
